Natalie comes to Endpoints News from Reuters, where she spent her formative years writing about the business of health. Based in London, she now covers all things biopharma, but is working on making her coverage statistically significant. She likes to cover the politics of health, the microbiome, the anti-infective space, cannabis-derived therapeutics, and the blood splattered field of neurological drug development. In her free time, she monitors her wildly fluctuating heartbeat whilst watching Arsenal FC (and enjoys long walks on the beach). Most days she can be found pretending to go the gym and feeding her family poorly conceived food.